September 9, 2009 - Integrated backscatter (IBS) images were acquired with transesophageal echocardiography (TEE) and 3-dimensional image reconstruction to identify an increase in atrial degeneration that might predict the occurrence of atrial fibrillation (AF) before left atrium (LA) dilation.

September 14, 2009 – The 13th Annual Scientific Meeting of the Heart Failure Society of America (HFSA) today featured four late breaking clinical trials at the Hynes Convention Center in Boston.

September 13, 2009 – Mayo Clinic researchers say that "teachable software" designed to mimic the human brain may help them diagnose cardiac infections without an invasive exam, according to findings being presented today at the Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC) in San Francisco.

September 14, 2009 – OrbusNeich's Genous Bio-engineered R stent is feasible and safe in patients who need coronary revascularization before undeferrable noncardiac surgery and have to discontinue dual anti-platelet therapy, according to a paper published online in the International Journal of Cardiology.

Sept. 14, 2009 – Abbott said today the Chinese State Food and Drug Administration (SFDA) has approved the XIENCE V Everolimus-Eluting Coronary Stent System for the treatment of coronary artery disease (CAD) – the leading cause of death in China.

September 14, 2009 – InfraReDx said it will highlight its LipiScan Coronary Imaging System at the Cardiovascular Research Foundation's (CRF) annual Transcatheter Cardiovascular Therapeutics (TCT) scientific meeting, Sept. 21-25 in San Francisco.

The LipiScan will be displayed in the emerging technologies section at booth 2410. InfraReDx events at TCT 2009 include:

September 14, 2009 - Coronary computed tomography angiography (CCTA) enables cardiac morphology with high and isotropic spatial resolution, according to a new study published in Journal of the American College of Cardiology, Volume 54, No. 13. September 22, 2009.


September 11, 2009 – Abbott said yesterday it reached an $410 million agreement to purchase Evalve Inc., the global leader in the development of devices for minimally invasive repair of cardiac mitral valves.

September 11, 2009 – Terumo Interventional Systems yesterday launched its Glidewire Advantage Peripheral Guidewire, a single wire that enables the operator to both cross the lesion and deliver interventional devices such as balloons and stents.

September 11, 2009 – Terumo Interventional Systems yesterday announced the expansion of its Pinnacle Destination Guiding Sheaths with an 8 French size to extend the range of interventional procedures that can be performed, including atherectomy and stent graft procedures.

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now